The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Hosted on MSN
Gilead Sciences to acquire Repare’s RP-3467
Gilead Sciences has signed an agreement to acquire Repare Therapeutics’ polymerase theta (Polθ) ATPase inhibitor, RP-3467. The transaction involves a total consideration of up to $30m to Repare and ...
Hosted on MSN
Repare Therapeutics sells RP-3467 program to Gilead
Repare Therapeutics ( (RPTX)) has issued an update. On December 23, 2025, Repare Therapeutics entered into an asset purchase agreement under which Gilead Sciences acquired all assets related to ...
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results